Clinical Trial Update: Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

View source ↗

Summary

The clinical trial evaluating whether abnormal REVEAL parameters can predict heart failure readmissions has been terminated, per the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Thomas Jefferson University | Conditions: Heart Failure | Status: TERMINATED